SSA
PRAX icon

Schonfeld Strategic Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,702
Closed -$4.23M – 2495
2025
Q2 		$4.23M Buy
100,702
+94,628
+1,558% +$3.6M 0.03% 619
2025
Q1 		$230K Sell
6,074
-37,026
-86% -$2.31M ﹤0.01% 1893
2024
Q4 		$3.32M Buy
43,100
+14,649
+51% +$1.06M 0.02% 632
2024
Q3 		$1.64M Buy
+28,451
New +$1.54M 0.01% 970
2024
Q2 		– Sell
-4,028
Closed -$246K – 2483
2024
Q1 		$246K Buy
+4,028
New +$181K ﹤0.01% 1722
2023
Q4 		– Sell
-42,170
Closed -$1.08M – 2151
2023
Q3 		$1.08M Sell
42,170
-5,815
-12% -$110K 0.01% 995
2023
Q2 		$828K Buy
47,985
+12,543
+35% +$192K 0.01% 1044
2023
Q1 		$430K Buy
35,442
+30,915
+683% +$1.3M ﹤0.01% 1226
2022
Q4 		$162K Sell
4,527
-2,940
-39% -$91.7K ﹤0.01% 2055
2022
Q3 		$254K Sell
7,467
-4,065
-35% -$203K ﹤0.01% 2191
2022
Q2 		$423K Buy
+11,532
New +$1.23M ﹤0.01% 1455
2021
Q4 		– Sell
-953
Closed -$265K – 2449
2021
Q3 		$265K Buy
+953
New +$259K ﹤0.01% 1596

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Schonfeld Strategic Advisors's PRAX Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Praxis Precision Medicines (PRAX) in Q3 2025, closing a stake of 100,702 shares — an estimated $4.23M sold.

Schonfeld Strategic Advisors first reported a position in PRAX in Q3 2021 and held it in 12 quarters. The position peaked at $4.23M in Q2 2025. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Praxis Precision Medicines position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 100,702 Praxis Precision Medicines shares in Q3 2025, an estimated $4.23M.
  • Schonfeld Strategic Advisors first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 12 quarters.
  • Schonfeld Strategic Advisors's Praxis Precision Medicines position peaked at $4.23M in Q2 2025.
  • 152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.